Atlas FDA

HYLAFORM, HYLAFORM PLUS, ND CAPTIQUE

FDA premarket approval P030032/S003 · decided 2005-07-01

Approval details

PMA number
P030032
Supplement
S003
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
HYLAFORM, HYLAFORM PLUS, ND CAPTIQUE
Generic name
Implant, dermal, for aesthetic use
Applicant
Genzyme Biosurgery
Date received
2005-04-20
Decision date
2005-07-01
Days to decision
72 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Cambridge, MA
Statement
APPROVAL OF THE POST-APPROVAL STUDY FOR THE DEVICE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
S-1150 PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM (K031554)Genzyme Biosurgery2003-07-25
MONODEK SYNTHETIC ABSORBABLE SURGICAL SUTURE (K030212)Genzyme Biosurgery2003-03-27
RADLITE TISSUE RETRACTOR SYSTEM (K022989)Genzyme Biosurgery2002-11-25
SAPH-LOOP LIGATING LOOP (K022410)Genzyme Biosurgery2002-08-20